Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

TechnocaP · Innovative technology for capsule filling machines to boost the pharmaceutical manufacturing process

H2020Status: CLOSED1 February 201831 May 2018EU funding €50,000Call H2020-SMEInst-2016-2017

TECHNOCAP project is based on the industrialisation and commercialisation of a cutting-edge technology for capsule filling machines capable to significantly improve productivity, flexibility and quality of production for pharmaceutical companies. The pioneer of this disruptive project is MG2 S.r.l., industrial company specialized in the design, manufacturing and marketing of automatic machines for pharmaceuticals.Capsules are the most versatile of all dosage forms, in which one or more medicinal and inert ingredients are enclosed in a small shell or container usually made of gelatine. Nowadays, the regulatory authorities (EMA, FDA) are increasing exponentially their demand in terms of quality and dosage accuracy of the finished product. In fact, current technological solutions are reaching their limits, directly affecting the small, medium and large size pharmaceutical companies and their derived supply chain (i.e. pharmacies and consumer patients).Working in close collaboration with our customers in the pharmaceutical sector to response to inefficient methods present in the market, MG2 conceives TECHNOCAP, an innovative technology for capsule filling machines to boost the pharmaceutical manufacturing process. This technolog is able, under production rate, to control 100% of the weight/presence of all filled capsules to guarantee optimum end product quality, while enabling in real-time continuous data collection, analysis and interpretation to be used in production and quality control activities. As this project addresses MG2 commercial and technical strategies, we strongly believe that it will contribute to boost the growth of our company achieving, after 5 years of exploitation, 11% of market penetration, 28M€ of accumulated gross profit translated into a ROI ≥ 8.18 (with 70 sold machines) and a company growth of 55 new people.

Consortium · 1 organisation

coordinator

MG2 - SRL

IT · €50,000

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.